Despite Healthy Protein Product Revenues, Bio-Rad Life Science Sales Down 2.2 Percent | GenomeWeb
Strong results in its protein research-related products could not bolster Bio-Rad Laboratories’ Life Science segment as sales in the division fell 2.2 percent to $141.6 million during the first quarter, compared to $144.8 million a year ago.
Profits in the division, which houses Bio-Rad’s proteomics business, plummeted 61 percent to $5.5 million from $14.1 million during the first quarter of 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.